These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Nitric oxide synthase inhibitors modulate lipopolysaccharide-induced hepatocyte injury: dissociation between in vivo and in vitro effects. Farghali H, Canová N, Kucera T, Martínek J, Masek K. Int Immunopharmacol; 2003 Nov; 3(12):1627-38. PubMed ID: 14555288 [Abstract] [Full Text] [Related]
23. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats. Soliman H, Craig GP, Nagareddy P, Yuen VG, Lin G, Kumar U, McNeill JH, Macleod KM. Cardiovasc Res; 2008 Jul 15; 79(2):322-30. PubMed ID: 18411229 [Abstract] [Full Text] [Related]
24. [Influence of selective versus nonselective inhibitors of nitric oxide synthases on synovial microcirculation of the knee joint of the mouse in vivo]. Veihelmann A, Krombach F, Refior HJ, Messmer K. Langenbecks Arch Chir Suppl Kongressbd; 1998 Jul 15; 115(Suppl I):197-201. PubMed ID: 14518242 [Abstract] [Full Text] [Related]
25. Nitric-oxide-dependent systemic immunosuppression in animals with progressively growing malignant gliomas. Hegardt P, Widegren B, Sjögren HO. Cell Immunol; 2000 Mar 15; 200(2):116-27. PubMed ID: 10753503 [Abstract] [Full Text] [Related]
26. Low-dose combretastatin A4 phosphate enhances the immune response of tumor hosts to experimental colon carcinoma. Badn W, Kalliomäki S, Widegren B, Sjögren HO. Clin Cancer Res; 2006 Aug 01; 12(15):4714-9. PubMed ID: 16899622 [Abstract] [Full Text] [Related]
27. Time-dependent aggravation or attenuation of lipopolysaccharide-induced gastric injury by nitric oxide synthase inhibition. Suliburk JW, Helmer KS, Kennison SD, Mercer DW, Robinson EK. J Surg Res; 2005 Dec 01; 129(2):265-71. PubMed ID: 16026802 [Abstract] [Full Text] [Related]
28. Selective inhibition of inducible nitric oxide synthase reduces neurological deficit but not cerebral edema following traumatic brain injury. Louin G, Marchand-Verrecchia C, Palmier B, Plotkine M, Jafarian-Tehrani M. Neuropharmacology; 2006 Feb 01; 50(2):182-90. PubMed ID: 16242164 [Abstract] [Full Text] [Related]
29. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN. Lee HJ, Oh YK, Rhee M, Lim JY, Hwang JY, Park YS, Kwon Y, Choi KH, Jo I, Park SI, Gao B, Kim WH. J Mol Biol; 2007 Jun 15; 369(4):967-84. PubMed ID: 17475277 [Abstract] [Full Text] [Related]
30. The radiosensitizing effect of immunoadjuvant OM-174 requires cooperation between immune and tumor cells through interferon-gamma and inducible nitric oxide synthase. De Ridder M, Verovski VN, Chiavaroli C, Van den Berge DL, Monsaert C, Law K, Storme GA. Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1473-80. PubMed ID: 17056198 [Abstract] [Full Text] [Related]
31. Nitric oxide involves in carnosine-induced hyperactivity in chicks. Tomonaga S, Tachibana T, Takahashi H, Sato M, Denbow DM, Furuse M. Eur J Pharmacol; 2005 Nov 07; 524(1-3):84-8. PubMed ID: 16236277 [Abstract] [Full Text] [Related]
32. Delayed and acute effects of interferon-gamma on activity of an inwardly rectifying K+ channel in cultured human proximal tubule cells. Nakamura K, Komagiri Y, Kojo T, Kubokawa M. Am J Physiol Renal Physiol; 2009 Jan 07; 296(1):F46-53. PubMed ID: 18945831 [Abstract] [Full Text] [Related]
33. Complementary roles of tumor necrosis factor alpha and interferon gamma in inducible microglial nitric oxide generation. Mir M, Tolosa L, Asensio VJ, Lladó J, Olmos G. J Neuroimmunol; 2008 Nov 15; 204(1-2):101-9. PubMed ID: 18703234 [Abstract] [Full Text] [Related]
34. Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages. Kim KW, Ha KT, Park CS, Jin UH, Chang HW, Lee IS, Kim CH. Vascul Pharmacol; 2007 Nov 15; 47(2-3):99-107. PubMed ID: 17553752 [Abstract] [Full Text] [Related]
35. Inducible nitric oxide synthase expression and erythropoietin production in human hepatocellular carcinoma cells. Yoshioka K, Thompson J, Miller MJ, Fisher JW. Biochem Biophys Res Commun; 1997 Mar 27; 232(3):702-6. PubMed ID: 9126339 [Abstract] [Full Text] [Related]
36. Interferon-gamma regulates chemokine expression and release in the human mast cell line HMC1: role of nitric oxide. Gilchrist M, Befus AD. Immunology; 2008 Feb 27; 123(2):209-17. PubMed ID: 17662042 [Abstract] [Full Text] [Related]
37. Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats. Nagareddy PR, McNeill JH, MacLeod KM. Eur J Pharmacol; 2009 Jun 02; 611(1-3):53-9. PubMed ID: 19344709 [Abstract] [Full Text] [Related]
38. Inducible nitric oxide synthase (iNOS) is not required for IL-2-induced hypotension and vascular leak syndrome in mice. Kondapaneni M, McGregor JR, Salvemini D, Laubach VE, Samlowski WE. J Immunother; 2008 May 02; 31(4):325-33. PubMed ID: 18391763 [Abstract] [Full Text] [Related]
39. Effects of the inducible nitric-oxide synthase inhibitor L-N(6)-(1-iminoethyl)-lysine on microcirculation and reactive nitrogen species generation in the kidney following lipopolysaccharide administration in mice. Wu L, Mayeux PR. J Pharmacol Exp Ther; 2007 Mar 02; 320(3):1061-7. PubMed ID: 17202403 [Abstract] [Full Text] [Related]
40. Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats. Malyshev E, Tazi KA, Moreau R, Lebrec D. J Gastroenterol Hepatol; 2007 Dec 02; 22(12):2195-201. PubMed ID: 18031380 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]